Clinical Trials in Salt Lake City

Showing 5001-5020 of 16,694 trials

A Phase 1 Study of ARC-001 in Participants Undergoing Third Molar Extraction

NCT06864884

The study will test the investigational product gel against placebo (which contains no active ingredient) to determine if it is safe after wisdom tooth extraction. The main questions the study will answer are: 1. How much of the investigational product is absorbed in the blood? 2. Are there side effects?

Acute Post Operative PainThird Molar Extraction Surgery

Arcato Laboratories, Inc.30 participantsStarted Feb 2025

Salt Lake City, Utah, United States

RECRUITINGPhase 17.5 miles

SNV1521 in Participants with Advanced Solid Tumors

NCT06220864

This study is testing a new medicine, SNV1521, for people with advanced cancers. The researchers want to find out if SNV1521 is safe, well-tolerated, and effective in treating solid tumors. They are investigating different doses in order to find the most effective and safe one. They are also investigating whether it can be combined with other cancer therapies.

Advanced Solid Tumor

Synnovation Therapeutics, Inc.200 participantsStarted Feb 2024

New Haven, Connecticut, United States • Philadelphia, Pennsylvania, United States • Nashville, Tennessee, United States +6 more locations

COMPLETEDPhase 2/319 miles

Safety and Immunogenicity of HIL-214 With Routine Pediatric Vaccines

NCT05836012

This is a phase 2, multi-country, randomized, double-blind, placebo-controlled trial to evaluate the immune response to routine pediatric vaccinations when co-administered with HIL-214 or placebo in healthy infants. This trial will also evaluate the safety profile of a 2-dose regimen of HIL-214 co-administered with routine pediatric vaccines.

Gastroenteritis

HilleVax329 participantsStarted Jun 2023

Lafayette, Louisiana, United States • Missoula, Montana, United States • Hastings, Nebraska, United States +9 more locations

A Phase 1 Study of ARC-001 in Participants Undergoing Third Molar Extraction

SNV1521 in Participants with Advanced Solid Tumors

Safety and Immunogenicity of HIL-214 With Routine Pediatric Vaccines

Find Trials by Condition in Salt Lake City

Tralokinumab Monotherapy for Moderate to Severe Atopic Dermatitis - ECZTRA 2 (ECZema TRAlokinumab Trial no. 2)

Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials - ECZTEND

Trial to Shorten Pharmacologic Treatment of Newborns With Neonatal Opioid Withdrawal Syndrome (NOWS)

Improving Pediatric COVID-19 Vaccine Uptake Using an mHealth Tool

WAveCrest Vs. Watchman TranssEptal LAA Closure to REduce AF-Mediated STroke 2

DUET Study: A Clinical Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Orally Administered TERN-501 as Monotherapy and in Combination With TERN-101 in Noncirrhotic Adults With Presumed Non-Alcoholic Steatohepatitis

A Phase 1/2 Trial of CLN-081 in Patients With Non-Small Cell Lung Cancer

ALXN1210 Versus Eculizumab in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With Eculizumab

A Study of NX-019 in Patients with Advanced, Epidermal Growth Factor Receptor (EGFR) Mutant Cancer

An Evaluation of LEO 138559 in Adults With Moderate to Severe Atopic Dermatitis.

Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over an 8-week Treatment Period in Adult Subjects With Atopic Dermatitis.

Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6).

Safety and Efficacy of TACLONEX Ointment in Adolescent Patients (Aged 12 to 17 Years) With Psoriasis Vulgaris

Vestibular Stimulation to Trigger Adipose Loss (VeSTAL) Clinical Trial

Safety and Efficacy of LEO 80185 Topical Suspension in Adolescent Subjects (Aged 12 to 17) With Scalp Psoriasis

Brain Injury Rehabilitation Improving the Transition Experience

Impact of CardiolRx on Myocardial Recovery in Patients With Acute Myocarditis